Annual Total Assets
$642.84 M
-$178.74 M-21.76%
31 December 2023
Summary:
Allogene Therapeutics annual total assets is currently $642.84 million, with the most recent change of -$178.74 million (-21.76%) on 31 December 2023. During the last 3 years, it has fallen by -$584.99 million (-47.64%). ALLO annual total assets is now -47.64% below its all-time high of $1.23 billion, reached on 31 December 2020.ALLO Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$589.12 M
-$57.76 M-8.93%
30 September 2024
Summary:
Allogene Therapeutics quarterly total assets is currently $589.12 million, with the most recent change of -$57.76 million (-8.93%) on 30 September 2024. Over the past year, it has dropped by -$123.21 million (-17.30%). ALLO quarterly total assets is now -53.19% below its all-time high of $1.26 billion, reached on 30 June 2020.ALLO Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.8% | -17.3% |
| 3 y3 years | -47.6% | -45.4% |
| 5 y5 years | -16.9% | -15.3% |
ALLO Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -47.6% | at low | -45.4% | +0.5% |
| 5 y | 5 years | -47.6% | at low | -53.2% | +0.5% |
| alltime | all time | -47.6% | -53.2% | +97.1% |
Allogene Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $589.12 M(-8.9%) |
| June 2024 | - | $646.88 M(+10.3%) |
| Mar 2024 | - | $586.35 M(-8.8%) |
| Dec 2023 | $642.84 M(-21.8%) | $642.84 M(-9.8%) |
| Sept 2023 | - | $712.33 M(-7.6%) |
| June 2023 | - | $770.97 M(+3.2%) |
| Mar 2023 | - | $746.87 M(-9.1%) |
| Dec 2022 | $821.58 M(-21.8%) | $821.58 M(-7.4%) |
| Sept 2022 | - | $887.57 M(-6.3%) |
| June 2022 | - | $947.64 M(-1.8%) |
| Mar 2022 | - | $964.63 M(-8.2%) |
| Dec 2021 | $1.05 B | $1.05 B(-2.6%) |
| Sept 2021 | - | $1.08 B(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $1.13 B(-4.4%) |
| Mar 2021 | - | $1.18 B(-4.0%) |
| Dec 2020 | $1.23 B(+71.1%) | $1.23 B(+0.4%) |
| Sept 2020 | - | $1.22 B(-2.9%) |
| June 2020 | - | $1.26 B(+82.8%) |
| Mar 2020 | - | $688.52 M(-4.1%) |
| Dec 2019 | $717.80 M(-7.2%) | $717.80 M(+3.2%) |
| Sept 2019 | - | $695.54 M(-5.2%) |
| June 2019 | - | $734.00 M(-2.1%) |
| Mar 2019 | - | $749.37 M(-3.2%) |
| Dec 2018 | $773.86 M(>+9900.0%) | $773.86 M(+77.8%) |
| Sept 2018 | - | $435.24 M(+45.6%) |
| June 2018 | - | $298.85 M |
| Dec 2017 | $0.00 | - |
FAQ
- What is Allogene Therapeutics annual total assets?
- What is the all time high annual total assets for Allogene Therapeutics?
- What is Allogene Therapeutics annual total assets year-on-year change?
- What is Allogene Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly total assets year-on-year change?
What is Allogene Therapeutics annual total assets?
The current annual total assets of ALLO is $642.84 M
What is the all time high annual total assets for Allogene Therapeutics?
Allogene Therapeutics all-time high annual total assets is $1.23 B
What is Allogene Therapeutics annual total assets year-on-year change?
Over the past year, ALLO annual total assets has changed by -$178.74 M (-21.76%)
What is Allogene Therapeutics quarterly total assets?
The current quarterly total assets of ALLO is $589.12 M
What is the all time high quarterly total assets for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly total assets is $1.26 B
What is Allogene Therapeutics quarterly total assets year-on-year change?
Over the past year, ALLO quarterly total assets has changed by -$123.21 M (-17.30%)